HRTX - Heron Therapeutics Inc. (HRTX) CEO Barry Quart on Q4 2021 Results - Earnings Call Transcript
Heron Therapeutics, Inc. (HRTX) Q4 2021 Results Conference Call February 28, 2022 04:30 PM ET Company Participants David Szekeres - EVP and COO Barry Quart - Chairman and CEO John Poyhonen - President and Chief Commercial Officer Conference Call Participants Brandon Folkes - Cantor Fitzgerald Josh Schimmer - Evercore Serge Belanger - Needham Kelly Shi - Jefferies Presentation Operator Good day, ladies and gentlemen, and thank you for standing by. Welcome to the Heron Therapeutics Q4 2021 Earnings Conference. As a reminder, this conference is being recorded. Now, I would like to turn the call over to David Szekeres, Executive Vice President, Chief Operating Officer. Please proceed. David Szekeres Thank you, Morena. Good afternoon, everyone, and thank you for joining us. With me today from Heron are Barry Quart, Chief Executive Officer and Chairman; John Poyhonen, President and Chief Commercial Officer; and Kimberly Manhard, Executive Vice President of Drug Development
For further details see:
Heron Therapeutics, Inc. (HRTX) CEO Barry Quart on Q4 2021 Results - Earnings Call Transcript